PAR 2.08% 24.5¢ paradigm biopharmaceuticals limited..

Ann: PAR Appoints Business Development Consultant, page-128

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 364 Posts.
    lightbulb Created with Sketch. 93
    Keep spoon feeding @Denial. Keep spoon feeding! You’ve been the voice of reason. Love your work.

    My personal views are, we have added SW due to his PR like knowledge of the current lie of the land and his skillset will allow PR to focus on taking the programs through the upcoming regulatory meetings whilst the commercial side of the company dots its i’s and crosses its t’s. Whether that is regional deals in far flung places or the big ones like AUS, USA, EU, China etc. Providing assistance, oversight or finding the deals themselves. So go get em SW.

    Time is ticking. We can’t spend time hiring new consultants and PR can’t spend time teaching them the ropes.

    SW has a high opinion of the asset. He has granular knowledge of 005 and 008 and OA disease and the heterogeneity that exists at grade 2/3/4 OA and how Zilosul is performing as an entity, making it look like a homogenous SAFE, DMOAD outcome for patients.

    He understands and can get to work, starting TODAY!

    Rip in to work today SW
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
0.005(2.08%)
Mkt cap ! $85.73M
Open High Low Value Volume
24.0¢ 25.0¢ 23.0¢ $132.4K 552.1K

Buyers (Bids)

No. Vol. Price($)
6 93605 24.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.5¢ 5156 2
View Market Depth
Last trade - 13.52pm 14/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.